Skip to content

HEMOTECH BELUX

Active Private limited companyfounded 2001active for 25 yearsBrouwerijstraat 14, 8680 KoekelareKBO/BCE: BE 0474.412.845 subsidiary of #6 company by total assets in Koekelare, Wholesale and retail trade sector
Part of the group 66 companies in 14 countries

Lifetime

19 annual accounts with figures on one time axis, 24 filings since 2002
peak of €1.5m in 2025
€1.5m▲ 3.4%
lowest -€285,130 in 2022
€23,980▼ 79.8%
peak of €859,416 in 2025
€859,416▲ 2.9%
€4.1m▲ 17.6%
peak of 11.4 FTE in 2024
10.6 FTE▼ 7.0%
Board9 names since 2001
4 directors and 3 others
Owners
100%
Documentsfilings and deeds
09-07-202622 days before the deadline
2025abbreviated format
Result from €118,944 to €23,980 (statutory auditor) and (representative) appointed 12-11Debts from €3.5m to €4.1mCash from €170 to €0

Key points

from the 2025 annual accounts

Result

€23,980 ▼ 79.8%
€119,0002024€24,0002025

The result fell in 2025 from €118,944 to €23,980.

Debts

€4.1m 83% of the balance sheet
Financial debts 15%Suppliers 28%Taxes and wages 7%Other 50%

Of this, €3.4m falls due within a year.

Investments

€48,324 0.3 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

11 employees on 31-12-2025
212021862022302023542024772025

In 2025, 7 employees joined and 7 left.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Four of the last ten came late. The 2019 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 4,686 companies had the same profile as HEMOTECH BELUX has now. Each dot stands for 12 companies, two years later.

96.9%
were still trading
1.9%
stopped another way
1.1%
went bankrupt
  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 4,686 companies, not a prediction for HEMOTECH BELUX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 01-07-2021
Director,
Director,
Director, since 22-10-2024
Auditor,
  • 100%score equity €23.4m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

(statutory auditor) and (representative) appointed General meeting of 29-10-2025 · Gazette deed
Resignations & appointments resigns as director · (director) and (director) appointed · and act as permanent representatives · General meeting of 07-10-2024 · Gazette deed
Capital contribution of €400,000 General meeting of 20-12-2023 · Gazette deed
Capital contribution of €400,000 Contribution by · and act as permanent representatives · General meeting of 22-12-2022 · Gazette deed
All 44 events

Comparable companies

same main activity, similar in size and age
Company
HEMOTECH BELUX Koekelare €5.0m €1.5m 17.3% 10.6
DHCare Belgium Zedelgem €2.8m €1.2m 47.7% 9.4
ROCKMED Rumst €6.0m €1.7m 53.7% 7.1
BIOMEDICAL DIAGNOSTICS Antwerp €3.5m €1.3m 70.2% 7.4
F CARE SYSTEMS Antwerp €3.1m €1.3m 52.9% 11.7
LABORATOIRES GILBERT BENELUX Lessines €3.2m €1.4m 32.2% 10.4
Europhar Genappe €3.5m €1.6m 6.6% 16.1

These companies have the same main activity as HEMOTECH BELUX: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.8m and €6m, founded between 1995 and 2003.

Official details

Source: KBO
Status
Active since 26-03-2001Normal situation
Registered office
20 active companies are registered at this addressSource: KBO register, as of 18 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2025
Establishment unit
2.331.814.2762800 Mechelen, since 01-06-2022
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

≈ €6.0mestimated
€5.0m▲ 14.8%
Employeeson 31-12-2025
11=
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Companies linked to HEMOTECH BELUX

Parent and group

Insights on HEMOTECH BELUX

HEMOTECH BELUX files the abbreviated format. That format states no turnover. The gross margin rose from €51,479 in 2007 to €1.5m in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HEMOTECH BELUX

What is the company number of HEMOTECH BELUX?
The company number of HEMOTECH BELUX is 0474.412.845. The VAT number is the same number with BE in front: BE 0474.412.845.
Where is HEMOTECH BELUX based?
The registered office is at Brouwerijstraat 14, 8680 Koekelare.Company details
What does HEMOTECH BELUX do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of HEMOTECH BELUX?
HEMOTECH BELUX is a private limited company (BV).
When was HEMOTECH BELUX founded?
HEMOTECH BELUX was founded on 26-03-2001.
Is HEMOTECH BELUX still active?
Yes, HEMOTECH BELUX is an active enterprise in the KBO register.
How many employees does HEMOTECH BELUX have?
HEMOTECH BELUX had an average of 10.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does HEMOTECH BELUX fall under?
In its 2025 annual accounts, HEMOTECH BELUX states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of HEMOTECH BELUX?
The turnover in financial year 2025 is ≈ €6.0m. This figure is estimated from the gross margin of €1.5m and 96 comparable companies (NACE 46). It probably lies between €3.7m and €10.0m.
Is HEMOTECH BELUX profitable?
In financial year 2025, HEMOTECH BELUX made a profit of €23,980.
Where can I find the annual accounts of HEMOTECH BELUX?
HEMOTECH BELUX filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HEMOTECH BELUX due?
HEMOTECH BELUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.